Production of monoclonal antibodies against the B700 murine melanoma antigen and their antimetastatic properties
- 1 February 1992
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1138 (2) , 109-114
- https://doi.org/10.1016/0925-4439(92)90049-s
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Suppression of established pulmonary metastases by murine melanoma-specific monoclonal antibodiesInternational Journal of Cancer, 1991
- Albuminoid molecules: A novel, variability-generating cell-surface receptor system?Medical Hypotheses, 1989
- The intracellular association of b700 and b50 murine melanoma antigens and their role in tumor rejectionInternational Journal of Cancer, 1989
- Use of syngeneic monoclonal antibodies in the therapy of disseminated myeloid leukemic cellsInternational Journal of Cancer, 1988
- Demonstration of B700 Cross-Reactive Antigens on Human and Other Animal MelanomasPigment Cell Research, 1988
- Melanoma antigens as modified normal gene sequencesLife Sciences, 1987
- Monoclonal antibody production to a B16 melanoma associated antigenInternational Journal of Cancer, 1985
- Malignant melanoma: Cross-reacting (common) tumor rejection antigensInternational Journal of Cancer, 1985
- Amino-terminal variation in melanoma antigensBiochemical and Biophysical Research Communications, 1984
- Demonstration and isolation of murine melanoma-associated antigenic surface proteinsBiochemical and Biophysical Research Communications, 1979